GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
Lesley A. Inker(Tufts Medical Center), Tom Greene(University Medical Center Groningen), Philip Kam‐Tao Li(Hospital Authority), Gerald J. Beck(Cleveland Clinic), Vlado Perkovic(New South Wales Department of Health), Hiddo J.L. Heerspink(University Medical Center Groningen), Andrew S. Levey(Tufts Medical Center), Christoph Wanner(Universitätsklinikum Würzburg), Josef Coresh(New York University), Edward F. Vonesh(Northwestern University), Hocine Tighiouart(Tufts University), Jian Ying(North China University of Science and Technology), Jürgen Floege(RWTH Aachen University), Andrew Simon(Harvard University), Ron T. Gansevoort(University Medical Center Groningen)
Cited by 295
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k